80.65 USD
+0.32 (+0.4%)
80.65 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 83% to IONS. The Buy consensus is the weighted average rating of the current analysts ratings.
IONS was analyzed by 30 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IONS.
In the previous month the buy percentage consensus was at a similar level.
IONS was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-15 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-12-09 | B of A Securities | Maintains | Buy -> Buy |
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-04 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-30 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-30 | Needham | Maintains | Buy -> Buy |
| 2025-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-30 | Raymond James | Reiterate | Strong Buy -> Strong Buy |
| 2025-10-30 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-08 | Needham | Maintains | Buy -> Buy |
| 2025-10-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-10-08 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-10-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-06 | Stifel | Maintains | Hold -> Hold |
| 2025-09-26 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-09-23 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-23 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-23 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-03 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2025-09-03 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-03 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-09-03 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-02 | Needham | Maintains | Buy -> Buy |
IONIS PHARMACEUTICALS INC / IONS FAQ
What is the consensus rating for IONS stock?
The consensus rating for IONIS PHARMACEUTICALS INC (IONS) is 82.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for IONS stock?
The number of analysts covering IONIS PHARMACEUTICALS INC (IONS) is 30.